Search

Your search keyword '"Naomoto, Yoshio"' showing total 672 results

Search Constraints

Start Over You searched for: Author "Naomoto, Yoshio" Remove constraint Author: "Naomoto, Yoshio"
672 results on '"Naomoto, Yoshio"'

Search Results

151. TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

152. Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest

155. The impact of triple drug immunosuppression on clinical results of cadaveric kidney transplantation: a comparison of conventional immunosuppression

157. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society

162. Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer

166. Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice

167. Jejunal interposition reconstruction with a stomach preserving esophagectomy improves postoperative weight loss and reflux symptoms for esophageal cancer patients

170. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer

171. Abstract 5701: Targeting KRAS lung cancer in vivo by pulmonary surfactant-mediated gene transfer

173. Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer

176. F-18 FDG PET/CT Contributes to More Accurate Detection of Lymph Nodal Metastasis From Actively Proliferating Esophageal Squamous Cell Carcinoma

177. Lugol-Voiding Lesions Are an Important Risk Factor for a Second Primary Squamous Cell Carcinoma in Patients With Esosphageal Cancer or Head and Neck Cancer

179. Abstract 4415: Inhibition of mammalian target of rapamycin (mTOR) signaling by Temsirolimus as a potential therapeutic strategy for esophageal cancer treatment

180. Abstract 590: Antiproliferative effects and signaling profiles of the novel HSP90 inhibitor NVP-AUY922 in non-small cell lung cancer

187. Abstract 1616: The anti-tumor effect of TAE226, dual inhibitor of FAK and IGF-IR, on non-small-cell lung cancer with EGFR mutation

188. Abstract 4165: The establishment of a new mouse model with orthotopic esophageal cancer showing the esophagostenosis

189. Abstract 2320: N-cadherin down-regulation has antitumor effects in esophageal cancer

192. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits an anticancer effect in esophageal adenocarcinoma in vitro and in vivo

194. IGF-IR and its inhibitors in gastrointestinal carcinomas (Review)

195. Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis

197. W1912 Preferential Upregulation of Heparanase and Cyclooxygenase-2 in Barrett's Esophageal Adenocarcinoma and in Intestinal-Type Gastric Carcinoma

199. W1749 Glutamine Deprived Diet Induces the Colonic Hemorrhage and Influences the Cell Cycle of the Colonic Epithelium and Causes Epithelial Cell Apoptosis in New Born Mice

200. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma

Catalog

Books, media, physical & digital resources